Symphony Pharma Life Sciences

Hyderabad, India Founded: 2008 • Age: 18 yrs
Offers contract research, custom synthesis, and API manufacturing for global pharma companies.
Annual revenue $1.3M Latest available
Total funding - Funding intelligence
Employees 49 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors 10 Brand Intelligence

About Symphony Pharma Life Sciences

Symphony Pharma Life Sciences is a company based in Hyderabad (India) founded in 2008 by Amar Reddy and Raju Sirisilla. It operates as a B2B and Enterprise Contracts. The company has 49 employees as of March 31, 2023. Symphony Pharma Life Sciences offers products and services including NCE Intermediates, API-Intermediates, API-Impurities, Building Blocks, and Specialty Chemicals. Symphony Pharma Life Sciences operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Hyderabad, India
  • Employees 49 as on 31 Mar, 2023
  • Founders Amar Reddy, Raju Sirisilla
  • Sectors
    Chemicals & Materials
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Symphony Pharma Lifesciences Private Limited
  • Date of Incorporation 05 Dec, 2007
  • Jurisdiction Kolthur Village, Telangana, India
Operational Areas
Chemicals & Materials → Pulp, Paper & Packaging Materials Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.31 M (USD)
    1.64
    as on Mar 31, 2023
  • Net Profit
    $106.54 K (USD)
    33.32
    as on Mar 31, 2023
  • EBITDA
    $140.03 K (USD)
    -42.15
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    49

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Symphony Pharma Life Sciences

Symphony Pharma Life Sciences offers a comprehensive portfolio of products and services, including NCE Intermediates, API-Intermediates, API-Impurities, Building Blocks, and Specialty Chemicals.

Product name locked
Category locked
Primary

Intermediates for new chemical entities in clinical trials

Product name locked
Category locked
Locked

Advanced intermediates for active pharmaceutical ingredients

Product name locked
Category locked
Locked

Synthesized impurities for drug testing and validation

Product name locked
Category locked
Locked

Chemical fragments for medicinal chemistry applications

Product name locked
Category locked
Locked

Non-pharma chemicals for various applications like electronics

Funding Insights of Symphony Pharma Life Sciences

Premium access

Detailed funding history for Symphony Pharma Life Sciences

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Symphony Pharma Life Sciences

Investments
Premium access

Investment portfolio details for Symphony Pharma Life Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Symphony Pharma Life Sciences

Premium access

Detailed financials for Symphony Pharma Life Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Symphony Pharma Life Sciences Comparisons

Symphony Pharma Life Sciences Primary company
Description
Offers contract research, custom synthesis, and API manufact...
Location
Hyderabad, India
Founded Year
2008
Annual Revenue
$1.31 M (USD)
Net Profit
$106.54 K (USD)
EBITDA
$140.03 K (USD)
Employees
49
As of 2023
Premium access

Peer comparison for Symphony Pharma Life Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Symphony Pharma Life Sciences

Symphony Pharma Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
APIs, intermediates, and biochemical reagents are developed and manufactured.
Locked Locked Locked
APIs are developed and manufactured for therapeutic areas.
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Premium access

Detailed competitors of Symphony Pharma Life Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Symphony Pharma Life Sciences

Premium access

Complete news archive for Symphony Pharma Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Symphony Pharma Life Sciences

Symphony Pharma Life Sciences was founded in 2008.

Symphony Pharma Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Mar 31, 2023, the latest employee count at Symphony Pharma Life Sciences is 49.

Annual revenue of Symphony Pharma Life Sciences is $1.31M as on Mar 31, 2023.

Symphony Pharma Life Sciences is a CRO and CDMO company established in 2008, focusing on drug discovery, development, and manufacturing services. It specializes in producing NCE intermediates, API intermediates, impurities, and specialty chemicals through efficient processes. Located in Hyderabad, India, and Plainsboro, USA, the company partners with global pharmaceutical and biotech firms to deliver cost-effective solutions for clinical trials and market exclusivity.

Symphony Pharma Life Sciences's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Symphony Pharma Life Sciences offers NCE Intermediates, API-Intermediates, API-Impurities, Building Blocks, and Specialty Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available